Table 3: Clinical Trials on Medium- and Long-term Outcomes of Reperfusion Therapies in Pulmonary Embolism

Belén Biscotti Rodil, Juan Duarte Torres, Irene Martín de Miguel, Alejandro Cruz Utrilla, Nicolás Maneiro Melón, Jorge Nuche Berenguer, Yolanda Revilla Ostolaza, Sergio Alonso Charterina, María Jesús López Gude, Carmen Jiménez López-Guarch, Fernando Arribas Ynsaurriaga, Pilar Escribano Subías, Maite Velázquez Martín

Explore the incidence of chronic thromboembolic pulmonary hypertension, post-pulmonary embolism syndrome, and the role of transcatheter therapy. Table 3: Clinical Trials on Medium- and Long-term Outcomes of Reperfusion Therapies in Pulmonary Embolism.

Citation:Interventional Cardiology 2025;20:e37.

DOI: https://doi.org/10.15420/icr.2024.50

This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. For commercial reuse please contact: info@radcliffe-group.com

Download Download PowerPoint